1.Portsmouth S et al. Cap-Dependent Endonuclease Inhibitor S-033188 for
the Treatment of Influenza: Results from a Phase 3, Randomized,
Double-Blind, Placebo- and Active-Controlled Study in Otherwise Healthy
Adolescents and Adults with Seasonal Influenza. ID Week 2017.
2.World Health Organization. Up to 650 000 people die of respiratory
diseases linked to seasonal flu each year [Internet; cited 2018 May 29].
Available from:
http://www.who.int/mediacentre/news/releases/2017/seasonal-flu/en/.
3.World Health Organization. Influenza (Seasonal) [Internet; cited 2018 May 29]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en.
4.Baxter D. Evaluating the case for trivalent or quadrivalent influenza vaccines. Hum Vaccin Immunother. 2016; 12(10):2712-2717.
5.Centers for Disease Control and Prevention. Estimated Influenza
Illnesses, Medical Visits, Hospitalizations, and Deaths Averted by
Vaccination in the United State. [Internet; cited 2018 June 06].
Available from: https://www.cdc.gov/flu/about/disease/2015-16.htm
6.Nair H, et al. Global burden of respiratory infections due to seasonal
influenza in young children: a systematic review and meta-analysis.
Lancet. 2011 Dec 3;378(9807):1917-30.
7.T. Noshi et al. S-033447/S-033188, a Novel Small Molecule Inhibitor of
Cap-dependent Endonuclease of Influenza A and B Virus: In Vitro
Antiviral Activity against Laboratory Strains of Influenza A and B Virus
in Madin-Darby Canine Kidney Cells. Poster presentation at OPTIONS IX,
August 2016
8.K.Taniguchi et al. Inhibitory Effect of S-033188, a novel inhibitor of
influenza virus cap-dependent endonuclease, against avian influenza
A/H7N9 virus in vitro and in vivo. Poster presentation at ESWI,
September 2017.
9.K.Taniguchi et al. Inhibitory Effect of S-033188/S-033447, a novel
inhibitor of influenza virus cap-dependent endonuclease, against highly
pathogenic avian influenza virus A/H5N1. Poster presentation at ECCMID,
April 2017.
